Corrigendum to “A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)”: [ESMO Open 9 (2024) 103668](ESMO Open (2024) 9(9), (S2059702924014376), (10.1016/j.esmoop.2024.103668))

E. J. Kang; Y. Yang; S. Lee; Y. J. Kim; S. M. Lim; M. J. Ahn; Y. J. Choi; Y. Lee; T. M. Kim; I. Kim; H. K. Ahn; H. C. Jeung; S. I. Lee; S. Y. Oh; W. K. Bae; H. Ryu; K. H. Park; K. H. Lee

doi:10.1016/j.esmoop.2025.104302

Corrigendum to “A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)”: [ESMO Open 9 (2024) 103668](ESMO Open (2024) 9(9), (S2059702924014376), (10.1016/j.esmoop.2024.103668))

E. J. Kang
, Y. Yang
, S. Lee
, Y. J. Kim
, S. M. Lim
, M. J. Ahn
, Y. J. Choi
, Y. Lee
, T. M. Kim
, I. Kim
, H. K. Ahn
, H. C. Jeung
, S. I. Lee
, S. Y. Oh
, W. K. Bae
, H. Ryu
, K. H. Park
, K. H. Lee^*

^*Corresponding author for this work

Department of Biomedical Sciences

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors regret that in the original publication Fig. 1A was given incorrectly. The full and correct Fig. 1 is now given below.[Figure presented] The authors would like to apologise for any inconvenience caused.

Original language	English
Article number	104302
Journal	ESMO Open
Volume	10
Issue number	4
DOIs	https://doi.org/10.1016/j.esmoop.2025.104302
Publication status	Published - 2025 Apr

Bibliographical note

Publisher Copyright:
© 2025 The Author(s)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/j.esmoop.2025.104302

Fingerprint

Dive into the research topics of 'Corrigendum to “A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)”: [ESMO Open 9 (2024) 103668](ESMO Open (2024) 9(9), (S2059702924014376), (10.1016/j.esmoop.2024.103668))'. Together they form a unique fingerprint.

Cite this

Kang, E. J., Yang, Y., Lee, S., Kim, Y. J., Lim, S. M., Ahn, M. J., Choi, Y. J., Lee, Y., Kim, T. M., Kim, I., Ahn, H. K., Jeung, H. C., Lee, S. I., Oh, S. Y., Bae, W. K., Ryu, H., Park, K. H., & Lee, K. H. (2025). Corrigendum to “A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)”: [ESMO Open 9 (2024) 103668](ESMO Open (2024) 9(9), (S2059702924014376), (10.1016/j.esmoop.2024.103668)). ESMO Open, 10(4), Article 104302. https://doi.org/10.1016/j.esmoop.2025.104302

Corrigendum to “A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)”: [ESMO Open 9 (2024) 103668](ESMO Open (2024) 9(9), (S2059702924014376), (10.1016/j.esmoop.2024.103668)). / Kang, E. J.; Yang, Y.; Lee, S. et al.
In: ESMO Open, Vol. 10, No. 4, 104302, 04.2025.

Research output: Contribution to journal › Comment/debate › peer-review

Kang, EJ, Yang, Y, Lee, S, Kim, YJ, Lim, SM, Ahn, MJ, Choi, YJ, Lee, Y, Kim, TM, Kim, I, Ahn, HK, Jeung, HC, Lee, SI, Oh, SY, Bae, WK, Ryu, H, Park, KH & Lee, KH 2025, 'Corrigendum to “A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)”: [ESMO Open 9 (2024) 103668](ESMO Open (2024) 9(9), (S2059702924014376), (10.1016/j.esmoop.2024.103668))', ESMO Open, vol. 10, no. 4, 104302. https://doi.org/10.1016/j.esmoop.2025.104302

Kang EJ, Yang Y, Lee S, Kim YJ, Lim SM, Ahn MJ et al. Corrigendum to “A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)”: [ESMO Open 9 (2024) 103668](ESMO Open (2024) 9(9), (S2059702924014376), (10.1016/j.esmoop.2024.103668)). ESMO Open. 2025 Apr;10(4):104302. doi: 10.1016/j.esmoop.2025.104302

@article{5eb177c9f5364c33ba1467297589ba8c,

title = "Corrigendum to “A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)”: [ESMO Open 9 (2024) 103668](ESMO Open (2024) 9(9), (S2059702924014376), (10.1016/j.esmoop.2024.103668))",

abstract = "The authors regret that in the original publication Fig. 1A was given incorrectly. The full and correct Fig. 1 is now given below.[Figure presented] The authors would like to apologise for any inconvenience caused.",

author = "Kang, \{E. J.\} and Y. Yang and S. Lee and Kim, \{Y. J.\} and Lim, \{S. M.\} and Ahn, \{M. J.\} and Choi, \{Y. J.\} and Y. Lee and Kim, \{T. M.\} and I. Kim and Ahn, \{H. K.\} and Jeung, \{H. C.\} and Lee, \{S. I.\} and Oh, \{S. Y.\} and Bae, \{W. K.\} and H. Ryu and Park, \{K. H.\} and Lee, \{K. H.\}",

note = "Publisher Copyright: {\textcopyright} 2025 The Author(s)",

year = "2025",

month = apr,

doi = "10.1016/j.esmoop.2025.104302",

language = "English",

volume = "10",

journal = "ESMO Open",

issn = "2059-7029",

publisher = "Elsevier B.V.",

number = "4",

}

TY - JOUR

T1 - Corrigendum to “A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)”

T2 - [ESMO Open 9 (2024) 103668](ESMO Open (2024) 9(9), (S2059702924014376), (10.1016/j.esmoop.2024.103668))

AU - Kang, E. J.

AU - Yang, Y.

AU - Lee, S.

AU - Kim, Y. J.

AU - Lim, S. M.

AU - Ahn, M. J.

AU - Choi, Y. J.

AU - Lee, Y.

AU - Kim, T. M.

AU - Kim, I.

AU - Ahn, H. K.

AU - Jeung, H. C.

AU - Lee, S. I.

AU - Oh, S. Y.

AU - Bae, W. K.

AU - Ryu, H.

AU - Park, K. H.

AU - Lee, K. H.

PY - 2025/4

Y1 - 2025/4

N2 - The authors regret that in the original publication Fig. 1A was given incorrectly. The full and correct Fig. 1 is now given below.[Figure presented] The authors would like to apologise for any inconvenience caused.

AB - The authors regret that in the original publication Fig. 1A was given incorrectly. The full and correct Fig. 1 is now given below.[Figure presented] The authors would like to apologise for any inconvenience caused.

UR - https://www.scopus.com/pages/publications/105000181002

U2 - 10.1016/j.esmoop.2025.104302

DO - 10.1016/j.esmoop.2025.104302

M3 - Comment/debate

C2 - 40112699

AN - SCOPUS:105000181002

SN - 2059-7029

VL - 10

JO - ESMO Open

JF - ESMO Open

IS - 4

M1 - 104302

ER -

Corrigendum to “A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)”: [ESMO Open 9 (2024) 103668](ESMO Open (2024) 9(9), (S2059702924014376), (10.1016/j.esmoop.2024.103668))

Abstract

Bibliographical note

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this